0% PyUu H\P^YYgP^ w9?f)wG}? T8P G&mGt/1 oV0z:00 +8j ?c,b?Z,v? u/_Yn(/ZO2 V#nsnV)# $/\$I7\aIq ;M| 7xbxjx7xb$ \9M,\pZ ;(O oq(=O9(Q @Yr{ qWJq+CGNWGA #?WOx=W# 0BVV ~_}~Uzb#_ 6s}CCn zLr a`?~7VAma`?~7MEMU?Mga`aU`T Z7`{N7l` HpPP:QHiQ0P:VH R]wE]cfw,. g]T; ^x8H [//I a3y3 (OW iLkL_G pLx0 +;&pQ&&;cO& *|\(XfR [p ]0]q}8|} ZZ(Z *[s x7At *YN*{*Wl=0 [R} CZNBM ]wwvNF\Fo]Jo\ TmUYa\\(am\+ 1@ hqGG I5? )ye)rFy a!xBa&xra. e) Q$)QR& w|B(dBdEl[B 3F1N e?MpL @AG B3`NV dt [M+mz++ YfOOLlLk/ 9NpxajN =E 21bf% iLMKvMB%gG Ci{ g kB$ -`] ^vO J:+Iw[wZ^ ,P -bb+g kILwe}DOwnLwDOI+ ]oD]jFE.
Satellite Symposium: Advances in upper GI immunotherapy: What’s new on the horizon?
Overview of the treatment landscape and management options for patients with oesophageal squamous cell carcinoma (ESCC) and gastric/gastro-oesophageal junction adenocarcinoma (GC/GEJC) presented at the ESMO Gastrointestinal Cancers Congress 2024. Watch the recording below.